Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Christine

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Renal Physiology and Biochemistry|January 1, 1990
Cation channels in the apical membrane of collecting duct principal cell epithelium in cultureF H Laskowski, C W Christine, A H Gitter, et al.
Neurology|April 11, 2008
Results from a phase I safety trial of hAADC gene therapy for Parkinson diseaseJ L Eberling, W J Jagust, C W Christine, et al.
Journal of Internal Medicine|February 27, 2020
What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studiesS Mathieson, G Wertheimer, C G Maher, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 5, 2018
Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysisOliver Enke, Heather A New, Charles H New, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 1998
Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptorsD V Lissin, S N Gomperts, R C Carroll, et al.
Neurology|October 16, 2009
Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseC W Christine, P A Starr, P S Larson, et al.
The New England Journal of Medicine|March 23, 2017
Trial of Pregabalin for Acute and Chronic SciaticaStephanie Mathieson, Christopher G Maher, Andrew J McLachlan, et al.
Parkinsonism & Related Disorders|April 1, 2014
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's diseaseA J H Moonen, A Wijers, A F G Leentjens, et al.
Pain|December 2, 2017
Core outcome measurement instruments for clinical trials in nonspecific low back painAlessandro Chiarotto, Maarten Boers, Richard A Deyo, et al.
Neurology|April 13, 2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseI H Richard, M P McDermott, R Kurlan, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Renal Physiology and Biochemistry|January 1, 1990
Cation channels in the apical membrane of collecting duct principal cell epithelium in cultureF H Laskowski, C W Christine, A H Gitter, et al.
Neurology|April 11, 2008
Results from a phase I safety trial of hAADC gene therapy for Parkinson diseaseJ L Eberling, W J Jagust, C W Christine, et al.
Journal of Internal Medicine|February 27, 2020
What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studiesS Mathieson, G Wertheimer, C G Maher, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 5, 2018
Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysisOliver Enke, Heather A New, Charles H New, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 1998
Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptorsD V Lissin, S N Gomperts, R C Carroll, et al.
Neurology|October 16, 2009
Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseC W Christine, P A Starr, P S Larson, et al.
The New England Journal of Medicine|March 23, 2017
Trial of Pregabalin for Acute and Chronic SciaticaStephanie Mathieson, Christopher G Maher, Andrew J McLachlan, et al.
Parkinsonism & Related Disorders|April 1, 2014
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's diseaseA J H Moonen, A Wijers, A F G Leentjens, et al.
Pain|December 2, 2017
Core outcome measurement instruments for clinical trials in nonspecific low back painAlessandro Chiarotto, Maarten Boers, Richard A Deyo, et al.
Neurology|April 13, 2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseI H Richard, M P McDermott, R Kurlan, et al.
Pageof 2